Ince Can
Department of Translational Physiology, Academic Medical Center, Amsterdam, The Netherlands.
Nephron Clin Pract. 2014;127(1-4):124-8. doi: 10.1159/000363203. Epub 2014 Sep 24.
Acute kidney injury (AKI) is a rapidly developing condition often associated with critical illness, with a high degree of morbidity and mortality, whose pathophysiology is ill understood. Recent investigations have identified the dysfunction of the renal microcirculation and its cellular and subcellular constituents as being central to the etiology of AKI. Injury is caused by inflammatory activation involving endothelial leucocyte interactions in combination with dysregulation of the homeostatis between oxygen, nitric oxide, and reactive oxygen species. Effective therapies expected to resolve AKI will have to control inflammation and restore this homeostasis. In order to apply and guide these therapies effectively, diagnostic tools aimed at physiological biomarkers of AKI for monitoring renal microcirculatory function in advance of changes in pharmacological biomarkers associated with structural damage of the kidney will need to be developed.
急性肾损伤(AKI)是一种常与危重症相关的迅速发展的病症,具有高度的发病率和死亡率,其病理生理学尚不清楚。最近的研究已确定肾微循环及其细胞和亚细胞成分的功能障碍是急性肾损伤病因的核心。损伤是由炎症激活引起的,涉及内皮细胞与白细胞的相互作用,同时氧、一氧化氮和活性氧之间的稳态调节失调。有望解决急性肾损伤的有效疗法必须控制炎症并恢复这种稳态。为了有效应用和指导这些疗法,需要开发针对急性肾损伤生理生物标志物的诊断工具,以便在与肾脏结构损伤相关的药理学生物标志物发生变化之前监测肾微循环功能。